Enjoy complimentary customisation on priority with our Enterprise License!
The womens health diagnostics market size is forecast to increase by USD 14.61 billion at a CAGR of 8.09% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. The rising prevalence of breast cancer and the global adoption of advanced diagnostic solutions, such as ultrasound devices and mammography systems, are major factors fueling market expansion. Additionally, stringent regulatory bodies are guiding in-vitro diagnostics manufacturers to develop and introduce accurate and reliable diagnostic tests for breast cancer, cervical cancer, prenatal genetic screening, and ovarian cancer testing. Hospitals and clinics are increasingly investing in these advanced diagnostic tools to improve patient care and outcomes. Key trends in the market include the integration of artificial intelligence and machine learning technologies to enhance diagnostic accuracy and efficiency.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.